Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-17-008307
Filing Date
2017-03-21
Accepted
2017-03-21 17:00:47
Documents
1
Period of Report
2017-03-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8349
  Complete submission text file 0000899243-17-008307.txt   9838
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Issuer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O AVISTA CAPITAL PARTNERS 65 EAST 55TH STREET, 18TH FLOOR NEW YORK NY 10022
Business Address
Venkataraman Sriram (Reporting) CIK: 0001550642 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36569 | Film No.: 17704769